Cancer Research KI - Grants
Cancer Research KI awards research grants in several categories to promote excellent young researchers, clinical research, innovative research and joint international research projects. All grants are announced openly and the applications undergo external review.
Open Grant Calls
Photo: Mayo ClinicCollaborative Call to Support Cancer Research - Mayo Clinic and Cancer Research KI 2025
The Mayo Clinic Comprehensive Cancer Center (MCCCC) and Cancer Research Karolinska Institutet (CRKI) are pleased to announce the 2025 Request for Applications (RFA) within the areas of breast cancer, other solid tumors, and hematologic malignancies with a submission deadline of April 4, 2025.
Photo: Getty ImagesTherapeutic Catalyst Grant
Cancer Research UK Therapeutic Catalyst Awards were launched in late 2021 and have been a great success. The scheme operates as a collaborative venture between research scientists and drug discoverers within Cancer Research Horizons to accelerate the translation of novel ideas for therapeutic discovery. Awards can be up to £250,000 to support a 12–18-month proposal. There are 3 rounds of applications per year held in February, June and October.
Next expression of interest deadline: 6 June 2025.
Outcome of Innovative and Interdisciplinary Grant Announcements
KI-Mayo collaborative grant Recipients
The Mayo Clinic Cancer Center and Karolinska Institutet are pleased to announce the 2022 recipients of the collaborative cancer call grants.
Blue Sky Research Grant Recipients
Project grants within cancer research for a well-defined innovative pilot project aiming at demonstrating proof of principle. One-year project grants.
Translational Seed Funding Grant Recipients
These project grants in cancer research to foster novel collaborations between basic and clinical scientists to address important problems in the area of translational cancer research.
Task Forces Focusing on Specific Cancers
Grants for Task Forces for Different Diagnoses (TFDD) have been awarded by Cancer Research KI. The aim of the initiative is to encourage KI and University Hospital based researchers to join forces around one major group of cancers.
Previous Funding Opportunities
Blue Sky Grant for Innovative Cancer Research & Technology 2024
Cancer Research KI hereby announces up to six project grants in cancer research for well-defined innovative pilot projects that aim to demonstrate proof-of-principle ideas.
Deadline of application: 30th of August 2024.
Collaborative Call to Support Cancer Research - Mayo Clinic and Cancer Research KI 2024
The Mayo Clinic Comprehensive Cancer Center (MCCCC) and Cancer Research Karolinska Institutet (CRKI) are pleased to announce the 2024 Request for Applications (RFA) within the areas of breast cancer, other solid tumors, and hematologic malignancies with a submission deadline of April 1, 2024.
Translational Seed Funding Grant 2023
Cancer Research KI hereby announces up to four project grants in cancer research to foster novel collaborations between basic and clinical scientists to address important problems in the area of translational cancer research.
Deadline: 27/October/2023
Task Forces for Different Diagnoses (TFDD)- Grant Call 2023
Cancer Research KI invites applications for support to Task Forces focusing on Specific Cancers.
Deadline for the Application: August 31, 2023.
Collaborative Call: 2023 Karolinska Institutet and Mayo Clinic Cancer Center
The Mayo Clinic Comprehensive Cancer Center and Karolinska Institutet are pleased to announce the 2023 Request for Applications (RFA) within the areas of breast cancer, other solid tumors, and hematologic malignancies with a submission deadline of March 31, 2023.
Blue Sky Grant for Innovative Cancer Research & Technology 2022
Cancer Research KI hereby announces up to six project grants in cancer research for well-defined innovative pilot projects that aim to demonstrate proof of principle.
Blue Sky Grant for Innovative Cancer Research & Technology 2021
Cancer Research KI hereby announces up to six project grants in cancer research for well-defined innovative pilot projects that aim to demonstrate proof of principle. Deadline 16th April 2021.
Translational Seed Funding Grant 2021
Cancer Research KI hereby announces up to six project grants in cancer research to foster novel collaborations between basic and clinical scientists to address important problems in the area of translational cancer research. Deadline 16th April 2021.
KI and Mayo Clinic Collaborative Call in Breast Cancer
The Mayo Clinic Cancer Center and Karolinska Institutet are pleased to announce the 2021 Request for Applications (RFA) within the area of breast cancer with a submission deadline of 1 st April 2021.
International Research Grants
KI and Mayo Clinic Cancer Center Collaborative Call in Breast Cancer
The objective of this funding is to provide support to initiate and enhance collaborations in breast cancer research between Mayo Clinic Cancer Center and Karolinska Institutet - Cancer Research KI. Submission deadline of April 1st, 2021
KI-MDACC Collaborative Grants/ SINF
As a Sister Insitution to MD Anderson Cancer Center we, KI/StratCan, participate in the Sister Institution Network Fund (SINF) annual grant calls.
Grant for Clinical Research visits to MD Anderson Cancer Center
Support for clinical research visits of 3-6 months at MD Anderson, of which one month is dedicated to clinical rotation.
International Clinical Post Doc Grant
StratCan International Clinical Postdoc grants within cancer research are intended for MDs at the residency or post-residency levels interested in going abroad for a postdoc.
KI-DKFZ Joint Project Grant
KI-DKFZ Joint Project Grants within basic and translational cancer research are joint two-year project grants between StratCan and the German Cancer Research Center (DKFZ).
Clinical Grants
Investigator-Initiated Clinical Trial Grant
The StratCan Grant for Investigator-Initiated Clinical Trial is a one year grant to support the planning and implementation of an investigator-initiated clinical trial.
StratCan Grants for Clinicians
StratCan Grants for Clinicians are aimed for MDs combining cancer research and post-residency clinical work.